Central Pharmaceuticals Ltd. reported earnings results for the full year ended June 30, 2023. For the full year, the company reported sales was BDT 29.33 million compared to BDT 26 million a year ago. Net loss was BDT 43.96 million compared to BDT 68.25 million a year ago.

Basic loss per share from continuing operations was BDT 0.37 compared to BDT 0.57 a year ago.